Colgate-Palmolive Company $CL Shares Sold by Panagora Asset Management Inc.

Panagora Asset Management Inc. trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 78.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 269,020 shares of the company's stock after selling 997,216 shares during the period. Panagora Asset Management Inc.'s holdings in Colgate-Palmolive were worth $24,454,000 at the end of the most recent reporting period.

• Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?

A number of other hedge funds and other institutional investors have also modified their holdings of CL. Westside Investment Management Inc. grew its position in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after buying an additional 130 shares in the last quarter. Saudi Central Bank acquired a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC boosted its holdings in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock valued at $30,000 after acquiring an additional 155 shares in the last quarter. Ransom Advisory Ltd acquired a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $33,000. Finally, Y.D. More Investments Ltd bought a new stake in Colgate-Palmolive during the first quarter worth approximately $37,000. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have issued reports on CL shares. Barclays decreased their price target on Colgate-Palmolive from $82.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 4th. The Goldman Sachs Group decreased their target price on Colgate-Palmolive from $106.00 to $91.00 and set a "buy" rating for the company in a research note on Thursday, October 2nd. Bank of America dropped their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a "buy" rating on the stock in a research report on Wednesday, October 8th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $80.00 to $77.00 and set an "underweight" rating for the company in a report on Monday, November 3rd. Finally, UBS Group lowered their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a "buy" rating on the stock in a research note on Monday, November 3rd. Nine research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $89.87.

• 3 Defensive Stocks to Buy as Economic Uncertainty Lingers

Get Our Latest Research Report on CL

Colgate-Palmolive Stock Performance

Shares of CL opened at $79.96 on Tuesday. The company has a 50-day moving average of $78.58 and a two-hundred day moving average of $84.37. The stock has a market cap of $64.45 billion, a price-to-earnings ratio of 22.46, a PEG ratio of 4.44 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

• Cleveland-Cliffs Rally Tops S&P 500, Can It Continue?

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the prior year, the firm earned $0.91 EPS. The firm's quarterly revenue was up 1.9% on a year-over-year basis. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, October 17th. Colgate-Palmolive's dividend payout ratio (DPR) is 58.26%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

• Five stocks we like better than Colgate-Palmolive
• How to Effectively Use the MarketBeat Ratings Screener
• Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
• How Investors Can Find the Best Cheap Dividend Stocks
• Congress Beat the Market Again—Here Are the 3 Stocks They Bought
• What Investors Need to Know to Beat the Market
• Go on a Shopping Spree With 3 Top Retail ETFs

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here